Submitted by reuters8361 in business
The U.S. Food and Drug Administration has approved Pfizer's <a href="https://www.reuters.com/markets/companies/PFE.N" target="_blank">(PFE.N)</a> drug to treat adults with an inflammatory bowel disease called ulcerative colitis, the company said on Friday.